Bill Maughan
Stock Analyst at Canaccord Genuity
(0.16)
# 4,322
Out of 4,966 analysts
17
Total ratings
22.22%
Success rate
-35.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics | Downgrades: Hold | $26 → $8.6 | $8.55 | +0.64% | 3 | Aug 6, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $150.76 | +26.03% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $53.05 | -15.17% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $2.20 | +581.82% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.08 | +733.33% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $32.24 | +107.82% | 3 | May 9, 2024 | |
| MRNA Moderna | Maintains: Hold | $91 → $106 | $24.47 | +333.18% | 3 | May 3, 2024 | |
| IPSC Century Therapeutics | Maintains: Buy | $22 → $24 | $0.50 | +4,699.04% | 1 | Mar 15, 2024 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $60 | $7.08 | +747.46% | 1 | Feb 21, 2024 | |
| MRUS Merus | Initiates: Buy | $45 | $66.10 | -31.92% | 1 | Nov 2, 2023 |
Y-mAbs Therapeutics
Aug 6, 2025
Downgrades: Hold
Price Target: $26 → $8.6
Current: $8.55
Upside: +0.64%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $150.76
Upside: +26.03%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $53.05
Upside: -15.17%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.20
Upside: +581.82%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.08
Upside: +733.33%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $32.24
Upside: +107.82%
Moderna
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $24.47
Upside: +333.18%
Century Therapeutics
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $0.50
Upside: +4,699.04%
Bicycle Therapeutics
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $7.08
Upside: +747.46%
Merus
Nov 2, 2023
Initiates: Buy
Price Target: $45
Current: $66.10
Upside: -31.92%